Corrigendum to “WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S637]
Titel:
Corrigendum to “WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S637]
Auteur:
Iulianiello, Pietro Viggiano, Davide Borriello, Margherita Joshi, Rashmi Perna, Alessandra Ingrosso, Diego Vastante, Angela